A live bivalent influenza vaccine based on a H9N2 virus strain

Vaccine

Volumn 28, Issue 3, 2010, Pages 673-680

  Wu, Rui ^a,e   Guan, Yi ^b   Yang, Zhongdong ^d   Chen, Jianjun ^a   Wang, Hanzhong ^a   Chen, Quanjiao ^a   Sui, Zhiwei ^a   Fang, Fang ^c   Chen, Ze ^a,c,d  

^a WUHAN INSTITUTE OF VIROLOGY   (China)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

^c HUNAN NORMAL UNIVERSITY   (China)

^d SHANGHAI INSTITUTE OF BIOLOGICAL PRODUCTS   (China)

^e UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

Author keywords

Bivalent vaccine; H9N2; Hemagglutinin; Influenza

Indexed keywords

AMANTADINE; INFLUENZA VACCINE; VIRUS ANTIBODY; VIRUS HEMAGGLUTININ;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ANTIGEN EXPRESSION; ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; IMMUNIZATION; INFLUENZA; INFLUENZA VIRUS A H1N1; INFLUENZA VIRUS A H9N2; MOUSE; NONHUMAN; PATHOGENICITY; PHENOTYPE; PRIORITY JOURNAL; VIRUS CHARACTERIZATION; VIRUS GENE; VIRUS HYBRID; VIRUS RECOMBINANT; VIRUS STRAIN;

ADMINISTRATION, INTRANASAL; ANIMALS; ANTIBODIES, VIRAL; GENOME, VIRAL; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA A VIRUS, H9N2 SUBTYPE; INFLUENZA VACCINES; MICE; MICE, INBRED BALB C; ORTHOMYXOVIRIDAE INFECTIONS; SURVIVAL ANALYSIS; VACCINES, ATTENUATED; VACCINES, SYNTHETIC; VIRAL PROTEINS; VIRULENCE;

EID: 71149104684     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2009.10.102     Document Type: Article

References (43)

1. Kemble G., and Greenberg H. Novel generations of influenza vaccines. Vaccine 21 16 (2003) 1789-1795
2. Palese P., and Garcia-Sastre A. Influenza vaccines: present and future. J Clin Invest 110 1 (2002) 9-13
3. Wareing M.D., and Tannock G.A. Live attenuated vaccines against influenza; an historical review. Vaccine 19 25-26 (2001) 3320-3330
4. Helenius A. Unpacking the incoming influenza virus. Cell 69 4 (1992) 577-578
5. Pinto L.H., Holsinger L.J., and Lamb R.A. Influenza virus M2 protein has ion channel activity. Cell 69 3 (1992) 517-528
6. Roberts P.C., Lamb R.A., and Compans R.W. The M1 and M2 proteins of influenza A virus are important determinants in filamentous particle formation. Virology 240 1 (1998) 127-137
7. Bourmakina S.V., and Garcia-Sastre A. The morphology and composition of influenza A virus particles are not affected by low levels of M1 and M2 proteins in infected cells. J Virol 79 12 (2005) 7926-7932
8. Cheung T.K., Guan Y., Ng S.S., Chen H., Wong C.H., Peiris J.S., et al. Generation of recombinant influenza A virus without M2 ion-channel protein by introduction of a point mutation at the 5′ end of the viral intron. J Gen Virol 86 Pt 5 (2005) 1447-1454
9. Watanabe T., Watanabe S., Ito H., Kida H., and Kawaoka Y. Influenza A virus can undergo multiple cycles of replication without M2 ion channel activity. J Virol 75 12 (2001) 5656-5662
10. Qiu M., Fang F., Chen Y., Wang H., Chen Q., Chang H., et al. Protection against avian influenza H9N2 virus challenge by immunization with hemagglutinin- or neuraminidase-expressing DNA in BALB/c mice. Biochem Biophys Res Commun 343 4 (2006) 1124-1131
11. Chen J., Fang F., Li X., Chang H., and Chen Z. Protection against influenza virus infection in BALB/c mice immunized with a single dose of neuraminidase-expressing DNAs by electroporation. Vaccine 23 34 (2005) 4322-4328
12. Hoffmann E., Stech J., Guan Y., Webster R.G., and Perez D.R. Universal primer set for the full-length amplification of all influenza A viruses. Arch Virol 146 12 (2001) 2275-2289
13. Hoffmann E., Neumann G., Kawaoka Y., Hobom G., and Webster R.G. A DNA transfection system for generation of influenza A virus from eight plasmids. Proc Natl Acad Sci USA 97 11 (2000) 6108-6113
14. Neumann G., Watanabe T., Ito H., Watanabe S., Goto H., Gao P., et al. Generation of influenza A viruses entirely from cloned cDNAs. Proc Natl Acad Sci USA 96 16 (1999) 9345-9350
15. Enami M., Luytjes W., Krystal M., and Palese P. Introduction of site-specific mutations into the genome of influenza virus. Proc Natl Acad Sci USA 87 10 (1990) 3802-3805
16. Garcia-Sastre A., Muster T., Barclay W.S., Percy N., and Palese P. Use of a mammalian internal ribosomal entry site element for expression of a foreign protein by a transfectant influenza virus. J Virol 68 10 (1994) 6254-6261
17. Luo G., Bergmann M., Garcia-Sastre A., and Palese P. Mechanism of attenuation of a chimeric influenza A/B transfectant virus. J Virol 66 8 (1992) 4679-4685
18. Bergmann M., Romirer I., Sachet M., Fleischhacker R., Garcia-Sastre A., Palese P., et al. A genetically engineered influenza A virus with ras-dependent oncolytic properties. Cancer Res 61 22 (2001) 8188-8193
19. Castrucci M.R., Hou S., Doherty P.C., and Kawaoka Y. Protection against lethal lymphocytic choriomeningitis virus (LCMV) infection by immunization of mice with an influenza virus containing an LCMV epitope recognized by cytotoxic T lymphocytes. J Virol 68 6 (1994) 3486-3490
20. Ferko B., Katinger D., Grassauer A., Egorov A., Romanova J., Niebler B., et al. Chimeric influenza virus replicating predominantly in the murine upper respiratory tract induces local immune responses against human immunodeficiency virus type 1 in the genital tract. J Infect Dis 178 5 (1998) 1359-1368
21. Garcia-Sastre A., and Palese P. Influenza virus vectors. Biologicals 23 2 (1995) 171-178
22. Palese P., Zavala F., Muster T., Nussenzweig R.S., and Garcia-Sastre A. Development of novel influenza virus vaccines and vectors. J Infect Dis 176 Suppl. 1 (1997) S45-S49
23. Palese P., Zheng H., Engelhardt O.G., Pleschka S., and Garcia-Sastre A. Negative-strand RNA viruses: genetic engineering and applications. Proc Natl Acad Sci USA 93 21 (1996) 11354-11358
24. Restifo N.P., Surman D.R., Zheng H., Palese P., Rosenberg S.A., and Garcia-Sastre A. Transfectant influenza A viruses are effective recombinant immunogens in the treatment of experimental cancer. Virology 249 1 (1998) 89-97
25. Vieira Machado A., Naffakh N., Gerbaud S., van der Werf S., and Escriou N. Recombinant influenza A viruses harboring optimized dicistronic NA segment with an extended native 5′ terminal sequence: induction of heterospecific B and T cell responses in mice. Virology 345 1 (2006) 73-87
26. Zheng H., Palese P., and Garcia-Sastre A. Antitumor properties of influenza virus vectors. Cancer Res 60 24 (2000) 6972-6976
27. Ferko B., Stasakova J., Sereinig S., Romanova J., Katinger D., Niebler B., et al. Hyperattenuated recombinant influenza A virus nonstructural-protein-encoding vectors induce human immunodeficiency virus type 1 Nef-specific systemic and mucosal immune responses in mice. J Virol 75 19 (2001) 8899-8908
28. Garulli B., Kawaoka Y., and Castrucci M.R. Mucosal and systemic immune responses to a human immunodeficiency virus type 1 epitope induced upon vaginal infection with a recombinant influenza A virus. J Virol 78 2 (2004) 1020-1025
29. Muster T., Ferko B., Klima A., Purtscher M., Trkola A., Schulz P., et al. Mucosal model of immunization against human immunodeficiency virus type 1 with a chimeric influenza virus. J Virol 69 11 (1995) 6678-6686
30. Luytjes W., Krystal M., Enami M., Pavin J.D., and Palese P. Amplification, expression, and packaging of foreign gene by influenza virus. Cell 59 6 (1989) 1107-1113
31. Dos Santos Afonso E., Escriou N., Leclercq I., van der Werf S., and Naffakh N. The generation of recombinant influenza A viruses expressing a PB2 fusion protein requires the conservation of a packaging signal overlapping the coding and noncoding regions at the 5′ end of the PB2 segment. Virology 341 1 (2005) 34-46
32. Kittel C., Ferko B., Kurz M., Voglauer R., Sereinig S., Romanova J., et al. Generation of an influenza A virus vector expressing biologically active human interleukin-2 from the NS gene segment. J Virol 79 16 (2005) 10672-10677
33. Machado A.V., Naffakh N., van der Werf S., and Escriou N. Expression of a foreign gene by stable recombinant influenza viruses harboring a dicistronic genomic segment with an internal promoter. Virology 313 1 (2003) 235-249
34. Percy N., Barclay W.S., Garcia-Sastre A., and Palese P. Expression of a foreign protein by influenza A virus. J Virol 68 7 (1994) 4486-4492
35. Zhou Y., Konig M., Hobom G., and Neumeier E. Membrane-anchored incorporation of a foreign protein in recombinant influenza virions. Virology 246 1 (1998) 83-94
36. Staczek J., Gilleland Jr. H.E., Gilleland L.B., Harty R.N., Garcia-Sastre A., Engelhardt O.G., et al. A chimeric influenza virus expressing an epitope of outer membrane protein F of Pseudomonas aeruginosa affords protection against challenge with P. aeruginosa in a murine model of chronic pulmonary infection. Infect Immun 66 8 (1998) 3990-3994
37. Maeda Y., Hatta M., Takada A., Watanabe T., Goto H., Neumann G., et al. Live bivalent vaccine for parainfluenza and influenza virus infections. J Virol 79 11 (2005) 6674-6679
38. Shinya K., Fujii Y., Ito H., Ito T., and Kawaoka Y. Characterization of a neuraminidase-deficient influenza a virus as a potential gene delivery vector and a live vaccine. J Virol 78 6 (2004) 3083-3088
39. Watanabe T., Watanabe S., Noda T., Fujii Y., and Kawaoka Y. Exploitation of nucleic acid packaging signals to generate a novel influenza virus-based vector stably expressing two foreign genes. J Virol 77 19 (2003) 10575-10583
40. Kittel C., Sereinig S., Ferko B., Stasakova J., Romanova J., Wolkerstorfer A., et al. Rescue of influenza virus expressing GFP from the NS1 reading frame. Virology 324 1 (2004) 67-73
41. Takeda M., Pekosz A., Shuck K., Pinto L.H., and Lamb R.A. Influenza a virus M2 ion channel activity is essential for efficient replication in tissue culture. J Virol 76 3 (2002) 1391-1399
42. Jackson D., Hossain M.J., Hickman D., Perez D.R., and Lamb R.A. A new influenza virus virulence determinant: the NS1 protein four C-terminal residues modulate pathogenicity. Proc Natl Acad Sci USA 105 11 (2008) 4381-4386
43. Jiao P., Tian G., Li Y., Deng G., Jiang Y., Liu C., et al. A single-amino-acid substitution in the NS1 protein changes the pathogenicity of H5N1 avian influenza viruses in mice. J Virol 82 3 (2008) 1146-1154